Literature DB >> 1571820

Altered distribution of IgG subclasses in aspirin-induced asthma: high IgG4, low IgG1.

A Szczeklik1, M Schmitz-Schumann, E Nizankowska, M Milewski, F Roehlig, C Virchow.   

Abstract

We have determined IgG subclass concentrations in 100 patients with aspirin-induced asthma and 80 healthy controls. Patients on chronic corticotherapy (n = 64) had significantly lower total IgG levels than patients not receiving steroids (n = 36) or controls. Corticotherapy was not associated with changes in the subclass distributions. In patients, the most striking finding was elevation of IgG4. It was not related to corticotherapy or serum IgE levels. The rise in IgG4 was accompanied by a modest, though statistically significant, depression of IgG1. No changes of IgG2 and IgG3 concentrations were observed. Thus, aspirin-induced asthma is characterized by a distinct pattern of distributions of IgG subclasses. It is suggested that in aspirin-induced asthma elevation of IgG4 might result from chronic antigenic stimulation, of viral origin, and that determination of IgG subclass distribution might be of clinical interest.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1571820     DOI: 10.1111/j.1365-2222.1992.tb03084.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

1.  IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Daniel F Dwyer; Jose Ordovas-Montanes; Howard R Katz; Erin Lewis; Marko Vukovic; Juying Lai; Lora G Bankova; Neil Bhattacharyya; Alex K Shalek; Nora A Barrett; Joshua A Boyce; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2020-03-19       Impact factor: 10.793

2.  Age related IgG subclass concentrations in asthma.

Authors:  P H Hoeger; B Niggemann; G Haeuser
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

Review 3.  Local immunoglobulin production in nasal tissues: A key to pathogenesis in chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Kathryn E Hulse
Journal:  Ann Allergy Asthma Immunol       Date:  2020-10-13       Impact factor: 6.347

4.  Role of Toll-like Receptor 3 Variants in Aspirin-Exacerbated Respiratory Disease.

Authors:  Nami Shrestha Palikhe; Seung-Hyun Kim; Joo-Hee Kim; Purevsuren Losol; Young-Min Ye; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-10-14       Impact factor: 5.764

5.  Genetic mechanisms in aspirin-exacerbated respiratory disease.

Authors:  Nami Shrestha Palikhe; Seung-Hyun Kim; Hyun Jung Jin; Eui-Kyung Hwang; Young Hee Nam; Hae-Sim Park
Journal:  J Allergy (Cairo)       Date:  2011-08-07

Review 6.  Update on recent advances in the management of aspirin exacerbated respiratory disease.

Authors:  Nami Shrestha Palikhe; Joo-Hee Kim; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.